Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Retained Earnings: 2020-2022

Historic Retained Earnings for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to -$99.1 million.

  • Candel Therapeutics' Retained Earnings fell 33.96% to -$125.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$125.9 million, marking a year-over-year decrease of 33.96%. This contributed to the annual value of -$99.1 million for FY2022, which is 23.41% down from last year.
  • Latest data reveals that Candel Therapeutics reported Retained Earnings of -$99.1 million as of FY2022, which was down 23.41% from -$80.3 million recorded in FY2021.
  • Candel Therapeutics' Retained Earnings' 5-year high stood at -$44.2 million during FY2020, with a 5-year trough of -$99.1 million in FY2022.
  • Over the past 3 years, Candel Therapeutics' median Retained Earnings value was -$80.3 million (recorded in 2021), while the average stood at -$74.5 million.
  • Data for Candel Therapeutics' Retained Earnings shows a maximum YoY tumbled of 81.78% (in 2021) over the last 5 years.
  • Over the past 3 years, Candel Therapeutics' Retained Earnings (Yearly) stood at -$44.2 million in 2020, then slumped by 81.78% to -$80.3 million in 2021, then fell by 23.41% to -$99.1 million in 2022.